DEFINITIVE PROXY STATEMENT

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 30, 1998

Period of Report

June 12, 1998

Accession Number

0001024739-98-000464

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →